Perbedaan Faal Hemostasis Pada Pasien Penyakit Jantung Koroner Dengan Dan Tanpa Diabetes Mellitus Tipe 2 Dengan Menggunakan Tromboelastografi (Teg)
57
DAFTAR KEPUSTAKAAN
1. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diabetes Care 2013;36:67–74.
2. PERKENI (2011). Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus
tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Stratmann B and Tschoepe D. Atherogenesis and atherothrombosis--focus on
diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2009; 23:291–303
4. Grant PJ. Inflammatory, atherothrombotic aspects of type 2 diabetes. Curr
Med Res Opin 2005; 21(Suppl1): S5–12
5. Gao Y, Lu B, Sun ML, Hou ZH, Yu FF, Cao HL, et al. Comparison of
atherosclerotic plaque by computed tomography angiography in patients with
and without diabetes mellitus and with known or suspected coronary artery
disease. Am J Cardiol. 2011;108(6): 809–813.
6. Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT,
et al. Outcomes in patients with diabetes mellitus undergoing percutaneous
coronary intervention in the current era: a report from the Prevention of
REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation.
2004;109(4): 476–480.
7. Natarajan A, Marshall SM, Worthley SG et al. The presence of coronary
artery disease increases platelet-dependent thrombosis in patients with type 2
diabetes mellitus. J Thromb Haemost 2008;6:2210–2213.
8. Viswanathan GN, Marshall SM, Schechter CB et al. Thrombus and
antiplatelet therapy in type 2 diabetes mellitus. A prospective study after nonST elevation acute coronary syndrome and a randomised, blinded, placebocontrolled study in stable angina. Thromb Haemost 2012, in press.
9. Egeberg O. The blood coagulability in diabetic patients. Scand J Clin Lab
Invest 1963;15:533–538
10. Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes
1993;42:8-11.
11. Small M, Kluft C, MacCuish AC, Lowe GDD. Tissue plasminogen activator
inhibition in diabetes mellitus. Diabetes Care 1989;12:655–658.
12. Panahloo A, Yudkin JS. Diminished fibrinolysis in diabetes mellitus and its
Universitas Sumatera Utara
58
implication for diabetic vascular disease. J Cardiovasc Res 1997;4:91–99
13. Traverso CI, Caprini JA, Arcelus JI. The normal thromboelastogram and its
interpretation. Semin Thromb Hemost 1995;21:7–13.
14. Spiel AO, Mayr FB, Firbas C, Ouehenberger P, Jilma B. Validation of
rotation thrombelastography in a model of systemic activation of fibrinolysis
and coagulation in humans. J Thromb Haemost 2005;4:411–416.
15. Yuerekli BPS, Oezcebe OI, Kirazlib S, Guerlek A. Global assessment of the
coagulation
status
in
type
2
diabetes
mellitus
using
rotation
thromboelastography. Blood Coagul Fibrinolysis 2006;17:545–549
16. Rodzynek JJ, Leautaud P, Martin T, Schoenwardfeld PL, Wettendorff P,
Delcourt A. Detection of procoagulant activity in acute ischaemic heart
disease. Thromb Res 1984; 33:355–360.
17. Ruggiero HA, Caprissi LF, Neuman J, de Caprissi ES. Treatment of acute
myocardial infarction with subcutaneous heparin at low doses. Clin Cardiol
1987;10:598–602.
18. Feuring M, Wehling M, Burkhardt H, Schultz A. Coagulation status in
coronary artery disease patients with type II diabetes mellitus compared with
non-diabetic coronary artery disease patients using the PFA-100 and
ROTEM. Platelets, December 2010; 21(8): 616–622
19. Goblirsch G, Bershow S, Cummings K, Hayes R, Kokoszka M, Lu Y,
Sanders D, Zarling K. Institute for Clinical Systems Improvement. Stable
Coronary Artery Disease. Updated May 2013.
20. Siracuse JJ, Chaikof EL. The Pathogenesis of Diabetic Atherosclerosis. G.V.
Shrikhande and J.F. McKinsey (eds.), Diabetes and Peripheral Vascular
Disease: Diagnosis and Management, Contemporary Diabetes,. New York
2012. 13-16
21. Beckman JA, Creager MA, Libby P. Diabetes and Atherosclerosis
Epidemiology, Pathophysiology, and Management. JAMA, May 15,
2002;287(19) : 2570-81
22. Bakte I Made. Hematologi klinik ringkas. Edisi-1. Jakarta :Penerbit EGC;
2006 hal233-254.
23. Mehta AB, Hoffbrand AV, Hematological aspect of systemic disease. In
Universitas Sumatera Utara
59
Hoffbrand AV, Tuden H, eds. Haematology at a glance. 1st ed. Oxford;
Blackwell, 2000; 78-81
24. Skeppholm M. Studies of Haemostasis In Acute Coronary Syndromes And
Diabetes Mellitus. Karolinska Institutet, Stockholm.2011
25. Benyamin AF. Gangguan Hemostasis Pada Diabetes Melitus. Ed: Sudoyo
AW, Setiati S, Alwi Idkk. Buku ajar penyakit dalam. Edisi 6. 2014; 28072808
26. Alzahrani SH, Ajjan RA. Coagulation and fibrinolysis in diabetes. Diabetes
& Vascular Disease Research. 2010.;7(4): 260-273
27. Ajjan R, Grant PJ. Coagulation and atherothrombotic disease. Atherosclerosis
186 (2006) 240–259
28. Frith D, Goslings JC, Gaarder C, et al. Definition and drivers of acute
traumatic coagulopathy: clinical and experimental investigations. J Thromb
Haemost 2010; 8:1919.
29. Thakur, M., Ahmed, A.B. A review of thromboelastography. International
Journal of Perioperative Ultrasound and Applied Technologies. 2012. 1: 2529
30. Luddington RJ. Thrombelastography/thromboelastometry. Clin. Lab. Haem.
2005, 27, 81–90
31. Essell.J.H, Martin.T.J, Salinas J, Thompson.J.M, and Smith.V.C. Comparison
of Thromboelastography to Bleeding Time and Standard Coagulation Tests in
Patients After Cardiopulmonary Bypass. Journal of cardiothoracic and
Vascular Anaesthesia, Vol 7, No 4(August), 1993: pp410- 415.
32. Kang YG, Martin DJ, Marquez J, et al. "Intraoperative Changes in Blood
Coagulation
and
[Thrombelastograph®]
Monitoring
in
Liver
Transplantation." Anesthesia and Analgesia. 1985. 64(9):888-896
33. Harjuna TSH. Perhitungan Besar Sampel. Mukhtar Z, Hrjuna TSH, Effendy
E, et al. Desain Penelitian Klinis dan Statistika Kedokteran. USU Press
2011.21
34. Mallett SV, Cox DJA. Thromboelastography. Br J Anaesth 1992;69:307–313
Universitas Sumatera Utara
60
35. Undas A, Areins RAS. Fibrin Clot Structure and Function: A Role in the
Pathophysiology Thromboembolic Disease. Arterioscler Thromb Vasc
Biol.2011. 31:e88-e99
36. Wu H, Qian J, Wang Q, Lv H, Sun A, Ge J. Thrombin induced platelet-fibrin
clot strength measured by thromboelastography is a novel marker of platelet
activation in acute myocardial infarction. Int J Cardiol 2014;172:e24-25
37. Hobson AR, Agarwala RA, Swallow RA, Dawkins KD, Curzen NP.
Thromboelastography: current clinical applications and its potential role in
interventional cardiology. Platelets 2006;17(8):509-18
38. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al.
Platelet reactivity in patients and recurrent events post-stenting. Results of the
PREPARE POST-STENTING study. J Am Coll Cardiol 2005;46:1820-6
39. Jax TW, Peters AJ, Plehn G, Schoebel FC. Hemostatic risk factors in patients
with coronary artery disease and type 2 diabetes – a two year follow-up of
243 patients. Cardiovasc Diabetol 2009;8:48–57
40. Artang R, Jensen E, Pedersen F, Frandsen NJ. Thrombelastography in healthy
volunteers, patients with stable angina and acute chest pain. Thrombosis
Research 2000;97:499–503
41. Stegenga ME, Van der Crabben SN, Levi M, De Vos AF, Tanck MW,
Sauerwein HP, et al. Hyperglycemia stimulates coagulations, whereas
hyperinsulinemia
impairs
fibrinolysis
in
healthy
humans.
Diabetes
2006;55:1807-1812
42. Kreating FK, Sobel BE, Schneider DJ. Effects of increased consentrations of
glucose on platelet reactivity in healthy subjects and in patients with and
without diabetes mellitus. Am J Cardiol 2003;92:1362-1365
43. Barillari G, Fabbro E, Pasca S, Bigotto E. Coagulation and oxidative stress
plasmatic levels in a type 2 diabetes population. Blood Coagul Fibrinolysis
2009;20:290–296
44. Verkleij CJN, Gerdes VEA, de Bruijn R, Meijers JCM, Marx PF. The
hemostatic system in patients with type 2 diabetes with and without
cardiovascular disease. J Thromb Haemostas 2009;7(Suppl 2):PP-WE-336
Universitas Sumatera Utara
DAFTAR KEPUSTAKAAN
1. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diabetes Care 2013;36:67–74.
2. PERKENI (2011). Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus
tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Stratmann B and Tschoepe D. Atherogenesis and atherothrombosis--focus on
diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2009; 23:291–303
4. Grant PJ. Inflammatory, atherothrombotic aspects of type 2 diabetes. Curr
Med Res Opin 2005; 21(Suppl1): S5–12
5. Gao Y, Lu B, Sun ML, Hou ZH, Yu FF, Cao HL, et al. Comparison of
atherosclerotic plaque by computed tomography angiography in patients with
and without diabetes mellitus and with known or suspected coronary artery
disease. Am J Cardiol. 2011;108(6): 809–813.
6. Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT,
et al. Outcomes in patients with diabetes mellitus undergoing percutaneous
coronary intervention in the current era: a report from the Prevention of
REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation.
2004;109(4): 476–480.
7. Natarajan A, Marshall SM, Worthley SG et al. The presence of coronary
artery disease increases platelet-dependent thrombosis in patients with type 2
diabetes mellitus. J Thromb Haemost 2008;6:2210–2213.
8. Viswanathan GN, Marshall SM, Schechter CB et al. Thrombus and
antiplatelet therapy in type 2 diabetes mellitus. A prospective study after nonST elevation acute coronary syndrome and a randomised, blinded, placebocontrolled study in stable angina. Thromb Haemost 2012, in press.
9. Egeberg O. The blood coagulability in diabetic patients. Scand J Clin Lab
Invest 1963;15:533–538
10. Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes
1993;42:8-11.
11. Small M, Kluft C, MacCuish AC, Lowe GDD. Tissue plasminogen activator
inhibition in diabetes mellitus. Diabetes Care 1989;12:655–658.
12. Panahloo A, Yudkin JS. Diminished fibrinolysis in diabetes mellitus and its
Universitas Sumatera Utara
58
implication for diabetic vascular disease. J Cardiovasc Res 1997;4:91–99
13. Traverso CI, Caprini JA, Arcelus JI. The normal thromboelastogram and its
interpretation. Semin Thromb Hemost 1995;21:7–13.
14. Spiel AO, Mayr FB, Firbas C, Ouehenberger P, Jilma B. Validation of
rotation thrombelastography in a model of systemic activation of fibrinolysis
and coagulation in humans. J Thromb Haemost 2005;4:411–416.
15. Yuerekli BPS, Oezcebe OI, Kirazlib S, Guerlek A. Global assessment of the
coagulation
status
in
type
2
diabetes
mellitus
using
rotation
thromboelastography. Blood Coagul Fibrinolysis 2006;17:545–549
16. Rodzynek JJ, Leautaud P, Martin T, Schoenwardfeld PL, Wettendorff P,
Delcourt A. Detection of procoagulant activity in acute ischaemic heart
disease. Thromb Res 1984; 33:355–360.
17. Ruggiero HA, Caprissi LF, Neuman J, de Caprissi ES. Treatment of acute
myocardial infarction with subcutaneous heparin at low doses. Clin Cardiol
1987;10:598–602.
18. Feuring M, Wehling M, Burkhardt H, Schultz A. Coagulation status in
coronary artery disease patients with type II diabetes mellitus compared with
non-diabetic coronary artery disease patients using the PFA-100 and
ROTEM. Platelets, December 2010; 21(8): 616–622
19. Goblirsch G, Bershow S, Cummings K, Hayes R, Kokoszka M, Lu Y,
Sanders D, Zarling K. Institute for Clinical Systems Improvement. Stable
Coronary Artery Disease. Updated May 2013.
20. Siracuse JJ, Chaikof EL. The Pathogenesis of Diabetic Atherosclerosis. G.V.
Shrikhande and J.F. McKinsey (eds.), Diabetes and Peripheral Vascular
Disease: Diagnosis and Management, Contemporary Diabetes,. New York
2012. 13-16
21. Beckman JA, Creager MA, Libby P. Diabetes and Atherosclerosis
Epidemiology, Pathophysiology, and Management. JAMA, May 15,
2002;287(19) : 2570-81
22. Bakte I Made. Hematologi klinik ringkas. Edisi-1. Jakarta :Penerbit EGC;
2006 hal233-254.
23. Mehta AB, Hoffbrand AV, Hematological aspect of systemic disease. In
Universitas Sumatera Utara
59
Hoffbrand AV, Tuden H, eds. Haematology at a glance. 1st ed. Oxford;
Blackwell, 2000; 78-81
24. Skeppholm M. Studies of Haemostasis In Acute Coronary Syndromes And
Diabetes Mellitus. Karolinska Institutet, Stockholm.2011
25. Benyamin AF. Gangguan Hemostasis Pada Diabetes Melitus. Ed: Sudoyo
AW, Setiati S, Alwi Idkk. Buku ajar penyakit dalam. Edisi 6. 2014; 28072808
26. Alzahrani SH, Ajjan RA. Coagulation and fibrinolysis in diabetes. Diabetes
& Vascular Disease Research. 2010.;7(4): 260-273
27. Ajjan R, Grant PJ. Coagulation and atherothrombotic disease. Atherosclerosis
186 (2006) 240–259
28. Frith D, Goslings JC, Gaarder C, et al. Definition and drivers of acute
traumatic coagulopathy: clinical and experimental investigations. J Thromb
Haemost 2010; 8:1919.
29. Thakur, M., Ahmed, A.B. A review of thromboelastography. International
Journal of Perioperative Ultrasound and Applied Technologies. 2012. 1: 2529
30. Luddington RJ. Thrombelastography/thromboelastometry. Clin. Lab. Haem.
2005, 27, 81–90
31. Essell.J.H, Martin.T.J, Salinas J, Thompson.J.M, and Smith.V.C. Comparison
of Thromboelastography to Bleeding Time and Standard Coagulation Tests in
Patients After Cardiopulmonary Bypass. Journal of cardiothoracic and
Vascular Anaesthesia, Vol 7, No 4(August), 1993: pp410- 415.
32. Kang YG, Martin DJ, Marquez J, et al. "Intraoperative Changes in Blood
Coagulation
and
[Thrombelastograph®]
Monitoring
in
Liver
Transplantation." Anesthesia and Analgesia. 1985. 64(9):888-896
33. Harjuna TSH. Perhitungan Besar Sampel. Mukhtar Z, Hrjuna TSH, Effendy
E, et al. Desain Penelitian Klinis dan Statistika Kedokteran. USU Press
2011.21
34. Mallett SV, Cox DJA. Thromboelastography. Br J Anaesth 1992;69:307–313
Universitas Sumatera Utara
60
35. Undas A, Areins RAS. Fibrin Clot Structure and Function: A Role in the
Pathophysiology Thromboembolic Disease. Arterioscler Thromb Vasc
Biol.2011. 31:e88-e99
36. Wu H, Qian J, Wang Q, Lv H, Sun A, Ge J. Thrombin induced platelet-fibrin
clot strength measured by thromboelastography is a novel marker of platelet
activation in acute myocardial infarction. Int J Cardiol 2014;172:e24-25
37. Hobson AR, Agarwala RA, Swallow RA, Dawkins KD, Curzen NP.
Thromboelastography: current clinical applications and its potential role in
interventional cardiology. Platelets 2006;17(8):509-18
38. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al.
Platelet reactivity in patients and recurrent events post-stenting. Results of the
PREPARE POST-STENTING study. J Am Coll Cardiol 2005;46:1820-6
39. Jax TW, Peters AJ, Plehn G, Schoebel FC. Hemostatic risk factors in patients
with coronary artery disease and type 2 diabetes – a two year follow-up of
243 patients. Cardiovasc Diabetol 2009;8:48–57
40. Artang R, Jensen E, Pedersen F, Frandsen NJ. Thrombelastography in healthy
volunteers, patients with stable angina and acute chest pain. Thrombosis
Research 2000;97:499–503
41. Stegenga ME, Van der Crabben SN, Levi M, De Vos AF, Tanck MW,
Sauerwein HP, et al. Hyperglycemia stimulates coagulations, whereas
hyperinsulinemia
impairs
fibrinolysis
in
healthy
humans.
Diabetes
2006;55:1807-1812
42. Kreating FK, Sobel BE, Schneider DJ. Effects of increased consentrations of
glucose on platelet reactivity in healthy subjects and in patients with and
without diabetes mellitus. Am J Cardiol 2003;92:1362-1365
43. Barillari G, Fabbro E, Pasca S, Bigotto E. Coagulation and oxidative stress
plasmatic levels in a type 2 diabetes population. Blood Coagul Fibrinolysis
2009;20:290–296
44. Verkleij CJN, Gerdes VEA, de Bruijn R, Meijers JCM, Marx PF. The
hemostatic system in patients with type 2 diabetes with and without
cardiovascular disease. J Thromb Haemostas 2009;7(Suppl 2):PP-WE-336
Universitas Sumatera Utara